Lifeward LTD 10-Q quarterly reports

Lifeward Ltd. reported a 16% revenue increase for Q2 2026 but faces substantial doubt regarding its ability to continue as a going concern due to ongoing net losses and negative cash flow.

Lifeward Ltd. reported a 6.4% revenue decrease for the nine months ended September 30, 2025, but improved gross profit margins and reduced operating cash burn, while facing a Nasdaq delisting notice and securing a $3.0 million loan.

Lifeward Ltd. reported increased net losses and a going concern warning for Q2 2025, despite significant capital raises and strategic product advancements.

Lifeward Ltd. reports a decrease in revenue for Q1 2025, alongside ongoing efforts to manage financial stability and expand market reach.

Lifeward Ltd. saw a significant increase in revenue in the third quarter of 2024, driven by expanded Medicare coverage and the integration of AlterG, while also announcing a streamlining of US operations.

Lifeward, formerly ReWalk Robotics, saw a significant increase in revenue in the second quarter of 2024, driven by the acquisition of AlterG and expanded Medicare coverage for its ReWalk Personal Exoskeleton.

Lifeward, formerly ReWalk Robotics, saw a 340% increase in revenue in Q1 2024 compared to Q1 2023, driven by the acquisition of AlterG and positive changes in Medicare reimbursement policies.